发明名称 |
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta |
摘要 |
Compounds that inhibit PI3Kδ activity, including compounds that selectively inhibit PI3Kδ activity, are disclosed. Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (PI3Kδ) activity, and methods of treating diseases, such as disorders of immunity and inflammation in which PI3Kδ plays a role in leukocyte function, using the compounds also are disclosed. Exemplary compounds disclosed in this application are shown below:; |
申请公布号 |
US8980901(B2) |
申请公布日期 |
2015.03.17 |
申请号 |
US201314049163 |
申请日期 |
2013.10.08 |
申请人 |
Icos Corporation |
发明人 |
Fowler Kerry W.;Huang Danwen;Kesicki Edward A.;Ooi Hua Chee;Oliver Amy;Ruan Fuqiang;Treiberg Jennifer;Puri Kamal Deep |
分类号 |
A61K31/517;C07D239/91;A61K31/52;C07D473/16;C07D473/34;C07D487/04 |
主分类号 |
A61K31/517 |
代理机构 |
Morrison & Foerster LLP |
代理人 |
Morrison & Foerster LLP |
主权项 |
1. A method of treating a hematological malignancy in a human, comprising administering to the human a compound selected from the group consisting of or a pharmaceutically acceptable salt thereof. |
地址 |
Foster City CA US |